Blog

Cynata Therapeutics granted another patent for its unique stem cell technology – Proactive Investors Australia


Proactive Investors Australia

Cynata Therapeutics granted another patent for its unique stem cell technology
Proactive Investors Australia
Cynata Therapeutics Ltd (ASX:CYP) has been granted a further patent covering aspects of its proprietary Cymerus™ stem cell platform by the U.S. Patent and Trademark Office (USPTO). The patent covers certain proprietary methods relating to the platform
Cynara's stem cell technology platform granted new US patentManufacturers’ Monthly



all 2 news articles »

2018-04-11 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.